Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

25th Sep 2014 07:00

RNS Number : 5518S
Regenersis PLC
25 September 2014
 

25 September 2014

 

REGENERSIS PLC (THE "COMPANY")

DIRECTORS' DEALINGS

 

 

 

The Company has been notified on 24 September 2014 that Hanover Investors bought 212,000 shares in the Company on 24 September 2014 at a price of 235p per share.

 

Following this, Hanover Investors and its connected parties are interested in 5,217,651 ordinary shares, representing 6.6% of the Company's issued share capital. Matthew Peacock and Tom Russell, both executive directors of the Company, have an indirect beneficial interest in the shares held by Hanover Investors.

 

The Company has also been notified on 24 September 2014 that Jog Dhody, Chief Financial Officer bought 12,500 shares in the Company on 24 September 2014 at a price of 235p per share.

 

Following this, Jog Dhody is interested in 418,081 ordinary shares, representing 0.5% of the Company's issued share capital.

 

 

Enquiries:

Regenersis Plc

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

+44 (0) 20 3657 7000

Panmure Gordon (UK) Limited (Nomad and Joint Broker)

Dominic Morley, Corporate Finance

Charles Leigh-Pemberton, Corporate Broking

 

+44 (0) 20 7886 2500

Cenkos Securities (Joint Broker)

Stephen Key, Corporate Finance

Alex Aylen, Sales

 

+44 (0) 20 7397 8900

Tavistock Communications

Catriona Valentine / Matt Ridsdale / Keeley Clarke

 

+44 (0) 20 7920 3150

 

About Regenersis

 

The technology aftermarket sector, in which Regenersis operates, provides services that improve the consumer or user experience after the initial purchase of a device. This area is becoming the cornerstone in how our clients seek to differentiate their brands and increase customer loyalty. Regenersis provides a range of hardware services (such as repair and logistics), software services (such as diagnostics) and managed services (such as device insurance programmes), which address these needs. Regenersis' clients include many of the world's largest technology brands.

 

www.regenersis.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIMPTMBTTBPI

Related Shares:

BLTG.L
FTSE 100 Latest
Value8,809.74
Change53.53